AMiCI on 10th Congress of Toxicology in Developing Countries (Belgrade, Serbia)

The Symposium “Antimicrobial coatings in healthcare settings: efficiency versus safety” Infections and infectious diseases are considered a major challenge to human health in healthcare units worldwide. As antimicrobial materials (such as silver and copper) are inherently toxic, the application of

The AMiCI COST Action on 2017 ECSJ in Copenhagen

The AMiCI Action has been selected, as one of 10 COST Actions, to be presented on this year’s European Conference for Science Journalists (Copenhagen, 26-30 June), the largest gathering of science journalists in Europe in 2017. This is a great chance to

COST multidisciplinary European research networks are key to FP9

On 15 June, the COST Committee of Senior Officials (CSO) published its position paper, highlighting the importance of multidisciplinary, bottom-up, open and inclusive networks, pleading for sufficient funding post Horizon 2020. Investment in research and innovation is key for the

Pori Ready to Welcome Participants of AMiCI meeting (June 6-8th)

Pori is ready to welcome participants of the second COST Action AMiCI conference. The final program of the meeting: Day 1 (6th of June) The Conference ‘Antimicrobial coatings in healthcare: from innovation to the market’. Key-note speakers will cover issues

PhD student positions available in the Marie-Sklodowska- Curie European Training Network “PRINT-AID”

Applications are invited for 9 PhD student positions available in the Marie-Sklodowska-Curie European Training Network: “PRINT-AID – Multidisciplinary European training network for development of personalized anti-infective medical devices combining printing technologies and antimicrobial functionality” within the Horizon 2020 Programme of the European Commission.

Anti-microbial coating innovations to prevent healthcare-associated infection

Commentary: Worldwide, millions of patients are affected annually by healthcare-associated infection (HCAI), impacting up to 80,000 patients in European Hospitals on any given day.[1] This represents not only public health risk, but also an economic burden. Through its Cooperation in Science and Technology

Twenty-nine countries join forces to prevent healthcare associated infectious diseases

Over sixty universities, research institutes and companies from twenty-nine European countries will jointly study the impact of applying antimicrobial (nano-)coatings on decreasing the spread of infections. The beneficial aspects of these measures will be assessed in the context of potential

Welcome at the AMiCI website!

AMiCI is the acronym of AntiMicrobial Coating Innovations. It is a consortium which was initiated by researchers at the Zuyd University of Applied Sciences in the Netherlands in 2012. AMiCI brings together stakeholders from different countries and disciplines, including knowledge

Research Coordination and Capacity-building Objectives

The main objective of AMiCI action is to develop, structure, coordinate and maintain a long-term, flexible and open European network in the field of AMC in healthcare. The scientific field encompasses R&D of materials and coatings, testing, legal aspects and

Rising threats from AntiMicriobial Resistance

Many efforts to reduce AMR have been initiated, are ongoing and have been concluded. However many of these have been proven to be only partially sufficient. In order to succeed, a holistic approach is needed (Communication from the Commission to